Use of the Impella Device for Acute Coronary Syndrome Complicated by Cardiogenic Shock - Experience From a Single Heart Center With Analysis of Long-term Mortality.Marco R. Schroeter, Wolfgang Schillinger, Gerd Hasenfuß et al.|PubMed|2016Cited by 33
Uncommon delayed and late complications after percutaneous left atrial appendage closure with Amplatzer® Cardiac PlugMarco R. Schroeter, Wolfgang Schillinger, Bernhard C. Danner et al.|Clinical Research in Cardiology|2013Cited by 30
Pro-thrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an Impella LP 2.5 heart pumpMarco R. Schroeter, Wolfgang Schillinger, Bernhard Unsöld et al.|Clinical Research in Cardiology|2012Cited by 27
Mid- to long-term outcome of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Data of the BVS registry Göttingen predominantly from ACS patientsKristian Hellenkamp, Marco R. Schroeter, Alexander Becker et al.|International Journal of Cardiology|2017Cited by 5
Successful Left Atrial Appendage Occlusion with the New Generation Amulet® Device after Late-Occurring Embolization of an Amplatzer® Cardiac Plug in a Patient with Repetitive StrokesMarco R. Schroeter, Wolfgang Schillinger|Case Reports in Cardiology|2016Cited by 0